Drug Abuse: FDA Advisers Recommend Approval of Titan Pharma’s Opioid Dependence Drug

FDA advisers recommend approval of Titan Pharma’s opioid dependence drug
Filed under: Drug Abuse

By Zeba Siddiqui (Reuters) – Advisers to the U.S. Food and Drug Administration recommended that Titan Pharmaceuticals Inc treatment for opioid addiction be approved, but were unconvinced that the company’s marketing plan was safe enough, given the potential for abuse of such drugs. The panel of advisers, who met in Silver Spring, Maryland to evaluate the safety and efficacy of Titan’s Probuphine …
{Source}